E
Eve M. Lackritz
Researcher at Centers for Disease Control and Prevention
Publications - 56
Citations - 6436
Eve M. Lackritz is an academic researcher from Centers for Disease Control and Prevention. The author has contributed to research in topics: Blood transfusion & Acquired immunodeficiency syndrome (AIDS). The author has an hindex of 36, co-authored 53 publications receiving 6019 citations. Previous affiliations of Eve M. Lackritz include Seattle Children's Research Institute & United States Department of Health and Human Services.
Papers
More filters
Journal ArticleDOI
Short-course oral zidovudine for prevention of mother-to-child transmission of HIV-1 in Abidjan, Côte d'Ivoire: a randomised trial
Stefan Z. Wiktor,Ehounou R. Ekpini,John M. Karon,John N. Nkengasong,Chantal Maurice,Sibailly T Severin,Thierry H. Roels,Moïse K Kouassi,Eve M. Lackritz,Issa-Malick Coulibaly,Alan E. Greenberg +10 more
TL;DR: Short-course oral zidovudine was safe, well tolerated, and decreased mother-to-child transmission of HIV-1 at age 3 months, and substantial efforts will be needed to ensure successful widespread implementation of such a regimen.
Journal ArticleDOI
The contribution of preterm birth to infant mortality rates in the United States.
TL;DR: The extreme prematurity of most of the infants and their short survival indicate that reducing infant mortality rates requires a comprehensive agenda to identify, to test, and to implement effective strategies for the prevention of preterm birth.
Journal ArticleDOI
Efficacy of trimethoprim-sulphamethoxazole prophylaxis to decrease morbidity and mortality in HIV-1-infected patients with tuberculosis in Abidjan, Côte d'Ivoire: a randomised controlled trial
Stefan Z. Wiktor,Madeleine Sassan-Morokro,Alison D. Grant,L. Abouya,John M. Karon,Chantal Maurice,Gaston Djomand,A. Ackah,Kouao Domoua,Auguste Kadio,Achy Yapi,Patrice Combe,Odette Tossou,Thierry H. Roels,Eve M. Lackritz,D. Coulibaly,Kevin M. De Cock,Issa-Malick Coulibaly,Alan E. Greenberg +18 more
TL;DR: In HIV-1-infected patients with tuberculosis, daily co-trimoxazole prophylaxis was well tolerated and significantly decreased mortality and hospital admission rates.
Journal ArticleDOI
Preventing preterm births: analysis of trends and potential reductions with interventions in 39 countries with very high human development index.
Hannah H Chang,Jim Larson,Hannah Blencowe,Catherine Y. Spong,Christopher P Howson,Sarah Cairns-Smith,Eve M. Lackritz,Shoo K. Lee,Elizabeth Mason,Andrew C Serazin,Salimah R. Walani,Joe Leigh Simpson,Joy E Lawn +12 more
TL;DR: The findings highlight the urgent need for research into underlying mechanisms of preterm births, and development of innovative interventions, and recommend a conservative target of a relative reduction in preterm birth rates of 5% by 2015.
Journal ArticleDOI
Assessment of a pilot antiretroviral drug therapy programme in Uganda: patients' response, survival, and drug resistance
Paul J. Weidle,Samuel S. Malamba,Raymond Mwebaze,Catherine Sozi,Gideon Rukundo,Robert Downing,Debra L. Hanson,Dorothy Ochola,P. Mugyenyi,Jonathan Mermin,Badara Samb,Eve M. Lackritz +11 more
TL;DR: Identification and treatment of patients earlier in the course of their illness and increased use of HAART could improve probability of survival and decrease drug resistance.